Skip to main content

First peanut allergy drug gets US approval

Biopharmaceutical company Aimmune Therapeutics says the US Food and Drug Administration has approved its drug to reduce, and potentially eliminate, allergic reactions to peanuts in children aged 4 to 17 and that it had priced it at $US890 ($A1,330) per month.

from Breaking News | Daily Telegraph https://ift.tt/2S3JX5k
Labels:

Comments

Post a Comment

Popular posts from this blog

20 Killed in Israeli Strikes as Israel and Hamas Trade Blame Over Truce

By Aaron Boxerman and Saher Alghorra from NYT World https://ift.tt/OzFTSBp
Post a Comment
Read more

LimeWire, Former File-Sharing Service, Is Revealed as Buyer of Fyre Festival

By Sopan Deb from NYT U.S. https://ift.tt/mO53Eit
Post a Comment
Read more

2025 Holiday Gift Guide

By Unknown Author from NYT U.S. https://ift.tt/V26QqEs
Post a Comment
Read more